Jaakko Matomaki
Overview
Explore the profile of Jaakko Matomaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
548
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heikkila A, Elovainio M, Raaska H, Matomaki J, Sinkkonen J, Lapinleimu H
PLoS One
. 2021 Jan;
16(1):e0245786.
PMID: 33493225
Aim: At arrival in new home country, internationally adopted children often have intestinal parasites. International adoptees also exhibit more behavioral problems than their biological peers. We examined whether intestinal parasite...
2.
Liuhto N, Gronroos M, Malila N, Madanat-Harjuoja L, Matomaki J, Lahteenmaki P
Int J Cancer
. 2019 Sep;
146(5):1324-1332.
PMID: 31523804
Modern cancer therapy has led to a growing number of pediatric and young adult cancer survivors, who are prone to increased morbidities caused by the late effects of therapy. The...
3.
Murtoniemi K, Villa P, Matomaki J, Keikkala E, Vuorela P, Hamalainen E, et al.
BMC Pregnancy Childbirth
. 2018 Jul;
18(1):279.
PMID: 29970026
Background: The proportion of hyperglycosylated human chorionic gonadotropin (hCG-h) to total human chorionic gonadotropin (%hCG-h) during the first trimester is a promising biomarker for prediction of early-onset pre-eclampsia. We wanted...
4.
Vallius T, Hynninen J, Kemppainen J, Alves V, Auranen K, Matomaki J, et al.
Eur J Nucl Med Mol Imaging
. 2018 Feb;
45(7):1224-1232.
PMID: 29476227
Objective: To evaluate the predictive potential of total metabolic tumor volume (MTV) reduction during neoadjuvant chemotherapy (NACT) with F-FDG-PET/CT in an advanced FIGO stage III/IV epithelial ovarian cancer (EOC) patient...
5.
Rita N, Elovainio M, Raaska H, Lahti-Nuuttila P, Matomaki J, Sinkkonen J, et al.
Scand J Psychol
. 2017 Jul;
58(4):312-317.
PMID: 28718969
International adoptees need to cope with stressful transitions and to develop secure attachment with their caregivers at the same time. Although most children adopted from abroad adjust fine, they are...
6.
Ahomaki R, Harila-Saari A, Parkkola K, Matomaki J, Lahteenmaki P
Acta Oncol
. 2017 Jul;
56(12):1712-1719.
PMID: 28712313
Background: Compromised physical fitness and cognitive difficulties have been reported as late effects of cancer treatment during childhood. To assess this issue, the military rankings of cancer survivors in medical...
7.
Gursoy M, Harju I, Matomaki J, Bryk A, Kononen E
Anaerobe
. 2017 Apr;
47:89-93.
PMID: 28438498
During the past decade, the clinically relevant genus Prevotella has expanded considerably. Prevotella species can be isolated from nearly all types of oral infections but also from various non-oral infections....
8.
Hamari L, Heinonen O, Aromaa M, Asanti R, Koivusilta L, Koski P, et al.
J Sch Health
. 2017 Mar;
87(4):236-243.
PMID: 28260241
Background: The basis of self-perceived physical competence is built in childhood and school personnel have an important role in this developmental process. We investigated the association between initial self-perceived physical...
9.
Vallius T, Hynninen J, Auranen A, Matomaki J, Oksa S, Roering P, et al.
Tumour Biol
. 2017 Feb;
39(2):1010428317691189.
PMID: 28218038
Primary chemotherapy treatment response monitoring in advanced epithelial ovarian cancer (EOC) is currently based on CT-imaging and serum CA125 values. Serum HE4 profile during first line chemotherapy has not been...
10.
Jambor I, Bostrom P, Taimen P, Syvanen K, Kahkonen E, Kallajoki M, et al.
J Magn Reson Imaging
. 2017 Feb;
46(4):1089-1095.
PMID: 28165653
Purpose: To evaluate the role of a 3T biparametric magnetic resonance imaging (bpMRI), T -weighted imaging, and three separate diffusion-weighted imaging acquisitions combined with targeted biopsy (TB) for improving risk...